Rallybio Corp (RLYB) is a biotechnology company listed on US.
Latest reported RLYB revenue for 2026-06-30 was $212.0K. Net income was $35.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RLYB currently screens at market cap $13.8M.
Use this RLYB page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RLYB quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RLYB SEC filings page. Lician reads the product cache first so this HTML stays unique to Rallybio Corp even when a live quote feed is slow.
Latest cached year on this hub. Full RLYB income, balance, and cash tables.